£2,104.00
1 mg
SARS-CoV-2 S1 Receptor-Binding Domain (S1-RBD) – Delta (B.1.617.2) HEK
Recombinant spike protein Receptor-Binding Domain (RBD) from SARS-CoV-2, Delta Variant (B.1.617.2), produced under serum-free conditions in HEK293 cells.
Predicted Molecular Mass: The SARS-CoV-2 S1 Receptor-Binding Domain (S1-RBD), B.1.617.2, after glycosylation predicts a molecular mass of 26 kDa. Glycosylated form runs at 25-40 kDa in gel electrophoresis.
nCoV Amino Acids: 319-541 aa (Accession No.QHD43416.1 )
Source: S1 Receptor-binding domain (RBD) of SARS-CoV-2 Delta Variant (aa 319-541) fused to the C-terminus with a 6xHis-tag.
Molecular weight: This molecule has a calculated mass of approximately 26 kDa. Glycosylate form runs at 25-40 kDa in gel electrophoresis.
Expression System: Mammalian; HEK
Tag: C-terminal 6 x His-tag.
Purity: >90%, as determined by analytical CGE under reducing conditions.
Mutations: L452R, T478K
Formulation: Liquid, 20mM NaPP, 300mM NaCl pH 7.2.
Concentration: > 0.5 mg/ml
Shipping: The liquid protein is shipped on Dry Ice.
Storage: The liquid protein needs to be stored between 2°C and 8°C upon receipt.
Usage: This product is for Research Use Only. It may not be used for therapeutics or diagnostic purposes.